SRZNNasdaq

Surrozen Inc.

Healthcare·Ophthalmology·Phase 1·South San Francisco, CA, United States
OphthalmologyInfectious Disease

Surrozen Inc. (SRZN): 5 pipeline candidates · ~26 mo cash runway. Updated within the last hour.

8.0/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway7.3

26.3 months

Financial Health10.0

D/E -1.43 · 0% dilution

Pipeline Maturity4.0

Lead: Phase 1

Pipeline Breadth8.5

5 candidates

Catalyst MomentumN/A

N/A

Insider Signal10.0

44 buys · 5 sells (180d)

A transparent, data-derived signal for Surrozen Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$290.1M

Cash

$107.6M

Quarterly Burn

$12.5M

Runway

26.3 mo

Revenue

$5.0M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Aug 2028
Today~29 mo out
Catalyst within runway

Pipeline (5 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

52

Total value held

$174.0M

HolderSharesValue
millennium management llc731,138$21.3M
stempoint capital lp721,620$19.2M
vivo capital, llc520,000$15.1M
perceptive advisors llc458,786$13.4M
woodline partners lp455,696$13.3M
braidwell lp396,100$11.5M
vestal point capital, lp338,611$9.9M
vanguard capital management llc338,184$9.9M
regents of the university of california266,414$7.8M
balyasny asset management l.p.203,888$5.9M

Showing top 10 of 52 institutional holders of Surrozen Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Craig C. Parker M.B.A.

Frequently asked questions

How many drug candidates are in Surrozen Inc.'s pipeline?

Surrozen Inc. (SRZN) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Surrozen Inc.'s lead drug candidate?

Surrozen Inc.'s most advanced tracked candidate is szn-043 (Phase 1) for severe alcohol-associated hepatitis.

What is Surrozen Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Surrozen Inc. has approximately 26.3 months of cash runway.

What is Surrozen Inc.'s market capitalization?

Surrozen Inc.'s market capitalization is approximately $290.1M.

Who is the CEO of Surrozen Inc.?

Mr. Craig C. Parker M.B.A. is the chief executive officer of Surrozen Inc. (SRZN).

Get the full picture on Surrozen Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.